首页> 外文期刊>Indian journal of Anaesthesia >A comparative study of attenuation of propofol-induced pain by lignocaine, ondansetron, and ramosetron
【24h】

A comparative study of attenuation of propofol-induced pain by lignocaine, ondansetron, and ramosetron

机译:利多卡因,恩丹西酮和雷莫司琼减轻丙泊酚引起的疼痛的比较研究

获取原文
           

摘要

Background and Aims: Propofol is widely used for induction of anaesthesia, although the pain during its injection remains a concern for all anaesthesiologists. A number of techniques have been adopted to minimise propofol-induced pain. Various 5-hydroxytryptamine-3 antagonists have shown to reduce propofol-induced pain. Hence, this placebo-controlled study was conducted to compare the efficacy of ondansetron, ramosetron and lignocaine in terms of attenuation of propofol-induced pain during induction of anaesthesia. Methods: Hundred and fifty adult patients, aged 18–60 years, posted for various elective surgical procedures under general anaesthesia were randomly assigned to three groups of 50 each. Group R received 0.3 mg of ramosetron, Group L received 0.5 mg/kg of 2% lignocaine and Group O received 4 mg of ondansetron. After intravenous (IV) pre-treatment of study drug, manual occlusion of venous drainage was done at mid-arm with the help of an assistant for 1 min. This was followed by administration of propofol (1%) after release of venous occlusion. Pain was assessed with a four-point scale. Unpaired Student's t-test and Chi-square test/Fisher's exact test were used to analyse results. Results: The overall incidence and intensity of pain were significantly less in Groups L and R compared to Group O (P ≤ 0.001). The incidence of mild to moderate pain in Groups O, R and L was 56%, 26% and 20%, respectively. The incidence of score '0' (no pain) was significantly higher in Group L (76%) and Group R (72%) than Group O (34%) (P Conclusion: Pre-treatment with IV ramosetron 0.3 mg is equally effective as 0.5 mg/kg of 2% lignocaine in preventing propofol-induced pain and both were better than ondansetron.
机译:背景与目的:异丙酚被广泛用于诱导麻醉,尽管注射过程中的疼痛仍然是所有麻醉医师关注的问题。已经采用了许多技术来最小化异丙酚引起的疼痛。各种5-羟色胺3拮抗剂已显示出可减轻丙泊酚引起的疼痛。因此,进行了这项安慰剂对照研究,比较了在麻醉诱导过程中恩丹西酮,雷莫司琼和利诺卡因在减轻异丙酚引起的疼痛方面的功效。方法:将一百五十名年龄在18至60岁的成年患者在全身麻醉下进行各种选择性手术,随机分为三组,每组50例。 R组接受0.3 mg雷莫司琼,L组接受0.5 mg / kg的2%利多卡因,O组接受4 mg恩丹西酮。在对研究药物进行静脉(IV)预处理后,在助手的帮助下,在手臂中部手动阻塞静脉引流1分钟。释放静脉闭塞后再给予异丙酚(1%)。用四点量表评估疼痛。未配对的学生t检验和卡方检验/费舍尔精确检验用于分析结果。结果:与O组相比,L组和R组的总体疼痛发生率和疼痛强度明显降低(P≤0.001)。 O,R和L组中轻度至中度疼痛的发生率分别为56%,26%和20%。 L组(76%)和R组(72%)得分为'0'(无疼痛)的发生率显着高于O组(34%)(P结论:静脉注射雷莫司琼0.3 mg治疗同样有效以0.5 mg / kg的2%利多卡因预防丙泊酚引起的疼痛,两者均优于恩丹西酮。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号